November 18th 2020: Praedicat press release on our participation in Lloyd’s Lab Cohort 5 Demo Day We are excited and proud of our work in the Lab! A tremendous THANK…
read moreFilter posts by:
Praedicat Participates in Identifying Emerging Chemicals of Concern: Tools and Strategies Chemicals in consumer and industrial goods are being scrutinized like never before. Rapidly developing information, in combination with increased…
read moreSpecialist research firm FinTech Global has announced the world’s most innovative solution providers addressing the digital transformation challenges and opportunities within insurance. And Praedicat is both proud and humbled to…
read moreOctober 20th 2020: Comprehensive coverage of dietary supplements is now available in ChemMeta®! Three-quarters of all U.S. adults report taking a dietary supplement. And the scary thing is that dietary…
read morePraedicat CEO Presents at Rand’s Opioid Symposium: There is still time to register for the Rand Corporation’s latest symposium: Opioid Litigation: What’s New and What Does It Mean for Future…
read moreOctober 13th, 2020: The APCIA article, “Lessons Learned: What COVID-19 has Taught the Re/Insurance Industry” summarizes and expands upon last week’s Intelligent Insurer’s Re/Insurance Lounge panel discussion, “COVID-19 Litigation and…
read moreThe “Toxic Trio” of hazardous cosmetic ingredients is now the “Toxic Twenty.” Responding to environmental and consumer protection organizations like the Environmental Working Group, the California state assembly in 2019…
read moreOctober 4th, 2020: In the RIMS Risk Management Monitor article, ‘‘Take-Home COVID-19’ Claims: Preparing for a Second Wave of Coronavirus Litigation’, Praedicat Head of Product and Chief Economist, Dr. David Loughran deliberates…
read moreImagine the sight and sound of a sofa engulfed in flames juxtaposed with the question “Are you sitting comfortably?” This last-minute media campaign by the industry-funded lobby Citizens for Fire…
read moreSeptember 28th, 2020: In the Reuters article, ‘Take Home’ Lawsuits Over COVID Infections Could be Costly for U.S. Employers, Praedicat CEO Robert Reville provides results from Praedicat’s suite of take-home COVID-19 scenarios. The Reuters’ article cites…
read morePraedicat Lloyd’s Lab Spotlight: In case you missed the Lloyd’s Lab Spotlight Presentation previewing some of Praedicat’s work as part of Cohort 5, you can watch the full video here.…
read moreSeptember 21st 2020: Comprehensive coverage of food additives is now available in ChemMeta®! Thousands of substances and chemicals are added to the processed foods we eat every day. Preservatives, anti-caking…
read more